Aspirin for the Primary Prevention of Cardiovascular Events

The U.S. Preventive Services Task Force (USPSTF) strongly recommends that clinicians discuss the benefits and harms of aspirin therapy with healthy adult patients at increased risk of coronary heart disease, primarily heart attacks.

The USPSTF Recommendations and Rationale—as well as the Summary of Evidence, a press release, and fact sheets—are available below.

Tip: For information on accessing PDF Files, go to PDF Help.

• Recommendations and Rationale (PDF File, 72 KB).
• Summary of the Evidence (PDF File, 240 KB).
• Press Release.
• What's New from the USPSTF (PDF File, 27 KB).
• Cardiovascular Risk Calculator.

Current as of January 2002

Internet Citation:

U.S. Preventive Services Task Force. Aspirin for the Primary Prevention of Cardiovascular Events. January 2002. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/aspirin/